Immunovant, Inc. (IMVT)
35.55
+9.26
(+35.22%)
USD |
NASDAQ |
May 20, 16:00
36.31
+0.76
(+2.14%)
After-Hours: 04:36
Immunovant Shareholders Equity (Quarterly) : 986.14M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | 11.96M |
| Perspective Therapeutics, Inc. | 347.44M |
| AVITA Medical, Inc. | -23.17M |
| Viridian Therapeutics, Inc. | 636.01M |
| Twist Bioscience Corp. | 455.09M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.052B |
| Total Liabilities (Quarterly) | 66.26M |
| Current Ratio | 15.74 |
| Net Debt Paydown Yield | 0.00% |